Home
products partnering science company contact

PeopleInvestorsCareersMediaMore facts

Media

Fact sheets

Corporate fact sheet

G-Technology® fact sheet

Press releases last 12 months

2011, December 19: to-BBB receives International Innovation grant to support partnership with top-5 pharma company

2011, September 29: NeuroVive and to-BBB awarded Eurostars grant for development of stroke therapy

2011, August 29: to-BBB builds for success with Chief Medical Officer and new group of investors

2011, July 19: EmulTech and to-BBB announce development partnership

2011, June 27: to-BBB starts clinical trial in patients with brain metastases

2011, June 27: to-BBB start klinische studie bij patiënten met hersentumoren

2011, March 31: to-BBB obtains government loan of €1.2 million for clinical trial in brain cancer

2011, February 31: to-BBB realizes €4M investment round

Media coverage last 12 months

2011, December 22: Nefarma: Dialoog to-BBB & Life Sciences Health (Dutch)

2011, October 15: Volkskrant: Via een sluipweg naar het brein (Dutch)

2011, October 14: Radio West: Bio Science Park Leiden groeit (Dutch radio)

2011, October 5: EuropaBio: to-BBB shortlisted for EuropaBio's Most Innovative European Biotech SME Award 2011

2011, September 8: DeGids.fm: Ontwikkeling van nieuw medicijn tegen hersentumoren (Dutch radio)

2011, May 7: BioNieuws: Medicijnen verpakt in lichaamseigen jasje (Dutch)

 

Visit the complete news archive here »

 
Contact
Niels Bohrweg 11
2333 CA Leiden
Leiden Bio Science Park
The Netherlands
Phone:
Fax:
+31 71 3322255
+31 84 8313409
to-BBB technologies BV

Copyright 2012 - to-BBB - disclaimer
Website by ratiodesign.nl
Photos by Aad van Vliet